Anitha Dhar, MD
Family Medicine · Smyrna, TNNPI 1215902796
Payments from drug & device makers
Across 257 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$664
- Novo Nordisk$613
- Lilly USA, LLC$499
- AstraZeneca$461
- Esperion Therapeutics, Inc.$245
- Pfizer$189
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,392100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $664 |
| Novo Nordisk | 37 | $613 |
| Lilly USA, LLC | 25 | $499 |
| AstraZeneca | 28 | $461 |
| Esperion Therapeutics, Inc. | 14 | $245 |
| Pfizer | 10 | $189 |
| Merck | 12 | $176 |
| Boehringer Ingelheim | 8 | $157 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $150 |
| GSK | 7 | $137 |
| Amgen | 7 | $130 |
| Exact Sciences | 7 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $101 |
| Shield Therapeutics Inc | 6 | $98 |
| Johnson & Johnson | 5 | $78 |
| Astellas Pharma US Inc | 3 | $76 |
| Axsome Therapeutics, Inc. | 4 | $67 |
| Advanced Bionics, LLC | 2 | $54 |
| Supernus Pharmaceuticals, Inc. | 3 | $53 |
| Nevro Corp. | 2 | $49 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Sanofi Pasteur Inc. | 2 | $32 |
| Optinose US, Inc. | 1 | $27 |
| Gilead | 2 | $26 |
| Novartis | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Abbott | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $15 |
| Endogastric Solutions, Inc | 1 | $14 |
| Eisai Inc. | 1 | $12 |
How this compares
$4,392 in reported general payments places this provider in the 80th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 36 | $37,941 |
| FarxigaDapagliflozin Propanediol | 25 | $33,393 |
| OzempicSemaglutide | 23 | $28,221 |
| JardianceEmpagliflozin | 24 | $26,141 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 25 | $21,969 |
| Xigduo XrDapaglifloz Propaned/Metformin | 16 | $16,360 |
| JanuviaSitagliptin Phosphate | 11 | $16,027 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 67 | $14,723 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $12,851 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $8,784 |
| LantusInsulin Glargine,hum.Rec.Anlog | 15 | $3,752 |
| Atorvastatin Calcium | 310 | $2,995 |
| Memantine Hcl ErMemantine Hcl | 17 | $2,769 |
| Fluticasone Propionate | 130 | $2,604 |
| Famotidine | 116 | $2,210 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanumet Xr, Januvia, Janumet | $176 | $50,84651 claims |
| PfizerEliquis | $189 | $37,94136 claims |
| AstraZenecaFarxiga | $461 | $33,39325 claims |
| Novo NordiskOzempic | $613 | $28,22123 claims |
| Boehringer IngelheimJardiance | $157 | $26,14124 claims |
| GSKShingrix | $137 | $14,72367 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Smyrna
- Sadia DarSmyrna$50K
- Frank WadeSmyrna$33K
- Joshua HixsonSmyrna$18K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.